About
Small Molecules Targeting Lysosomes
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (12)
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
258
By Phase
PHASE2: 2PHASE1: 1PHASE1/PHASE2: 1
By Status
TERMINATED: 2UNKNOWN: 2
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05448677Collaborator
Ezurpimtrostat Autophagy Inhibitor in Association With Atezolizumab-Bevacizumab in First Line Treatment of Unresectable Hepatocellular Carcinoma
PHASE2Terminated
3 participants
Started: Dec 15, 2022 · Completed: Mar 8, 2024
NCT05353894Lead Sponsor
Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GNS561 After One Single Dose (50 and 200mg) in Healthy Volunteers
PHASE1Unknown
27 participants
Started: May 2, 2022 · Completed: Nov 30, 2022
NCT04637828Lead Sponsor
A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection
PHASE2Unknown
178 participants
Started: Nov 18, 2020 · Completed: Dec 30, 2021
NCT03316222Lead Sponsor
Study of GNS561 in Patients With Liver Cancer
PHASE1/PHASE2Terminated
50 participants
Started: Apr 4, 2018 · Completed: Apr 25, 2022
Locations (1)
Headquarters
Marseille, France
Map
Loading map...